Annual Working Capital:
$529.01M-$354.11M(-40.10%)Summary
- As of today, NTLA annual working capital is $529.01 million, with the most recent change of -$354.11 million (-40.10%) on December 31, 2024.
- During the last 3 years, NTLA annual working capital has fallen by -$114.46 million (-17.79%).
- NTLA annual working capital is now -51.48% below its all-time high of $1.09 billion, reached on December 31, 2022.
Performance
NTLA Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Working Capital:
$488.21M+$87.77M(+21.92%)Summary
- As of today, NTLA quarterly working capital is $488.21 million, with the most recent change of +$87.77 million (+21.92%) on September 30, 2025.
- Over the past year, NTLA quarterly working capital has dropped by -$117.00 million (-19.33%).
- NTLA quarterly working capital is now -55.22% below its all-time high of $1.09 billion, reached on December 31, 2022.
Performance
NTLA Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
NTLA Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -40.1% | -19.3% |
| 3Y3 Years | -17.8% | -32.9% |
| 5Y5 Years | +108.4% | +35.5% |
NTLA Working Capital Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -51.5% | at low | -55.2% | +21.9% |
| 5Y | 5-Year | -51.5% | +108.4% | -55.2% | +35.5% |
| All-Time | All-Time | -51.5% | +6704.0% | -55.2% | +788.0% |
NTLA Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $488.21M(+21.9%) |
| Jun 2025 | - | $400.45M(-8.7%) |
| Mar 2025 | - | $438.80M(-17.1%) |
| Dec 2024 | $529.01M(-40.1%) | $529.01M(-12.6%) |
| Sep 2024 | - | $605.22M(-7.2%) |
| Jun 2024 | - | $652.12M(-17.0%) |
| Mar 2024 | - | $786.13M(-11.0%) |
| Dec 2023 | $883.12M(-19.0%) | $883.12M(+10.2%) |
| Sep 2023 | - | $801.54M(-4.6%) |
| Jun 2023 | - | $839.76M(-2.4%) |
| Mar 2023 | - | $860.29M(-21.1%) |
| Dec 2022 | $1.09B(+69.4%) | $1.09B(+49.8%) |
| Sep 2022 | - | $727.82M(-5.7%) |
| Jun 2022 | - | $771.67M(+3.0%) |
| Mar 2022 | - | $749.26M(+16.4%) |
| Dec 2021 | $643.47M(+16.5%) | $643.47M(-10.3%) |
| Sep 2021 | - | $717.21M(+50.9%) |
| Jun 2021 | - | $475.44M(-12.0%) |
| Mar 2021 | - | $540.38M(-2.2%) |
| Dec 2020 | $552.26M | $552.26M(+53.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $360.38M(-6.9%) |
| Jun 2020 | - | $387.23M(+65.2%) |
| Mar 2020 | - | $234.46M(-7.6%) |
| Dec 2019 | $253.85M(-10.7%) | $253.85M(-1.8%) |
| Sep 2019 | - | $258.42M(-3.8%) |
| Jun 2019 | - | $268.67M(+1.6%) |
| Mar 2019 | - | $264.46M(-7.0%) |
| Dec 2018 | $284.40M(-12.1%) | $284.40M(+4.2%) |
| Sep 2018 | - | $272.91M(-6.7%) |
| Jun 2018 | - | $292.46M(-6.3%) |
| Mar 2018 | - | $312.14M(-3.5%) |
| Dec 2017 | $323.47M(+29.1%) | $323.47M(+59.1%) |
| Sep 2017 | - | $203.27M(-7.4%) |
| Jun 2017 | - | $219.55M(-7.0%) |
| Mar 2017 | - | $236.17M(-5.7%) |
| Dec 2016 | $250.58M(+274.4%) | $250.58M(-7.2%) |
| Sep 2016 | - | $270.07M(-4.0%) |
| Jun 2016 | - | $281.29M(+411.6%) |
| Mar 2016 | - | $54.98M(-17.9%) |
| Dec 2015 | $66.93M(+760.8%) | $66.93M |
| Dec 2014 | $7.78M | - |
FAQ
- What is Intellia Therapeutics, Inc. annual working capital?
- What is the all-time high annual working capital for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. annual working capital year-on-year change?
- What is Intellia Therapeutics, Inc. quarterly working capital?
- What is the all-time high quarterly working capital for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. quarterly working capital year-on-year change?
What is Intellia Therapeutics, Inc. annual working capital?
The current annual working capital of NTLA is $529.01M
What is the all-time high annual working capital for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high annual working capital is $1.09B
What is Intellia Therapeutics, Inc. annual working capital year-on-year change?
Over the past year, NTLA annual working capital has changed by -$354.11M (-40.10%)
What is Intellia Therapeutics, Inc. quarterly working capital?
The current quarterly working capital of NTLA is $488.21M
What is the all-time high quarterly working capital for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high quarterly working capital is $1.09B
What is Intellia Therapeutics, Inc. quarterly working capital year-on-year change?
Over the past year, NTLA quarterly working capital has changed by -$117.00M (-19.33%)